<code id='C4B7B1A47F'></code><style id='C4B7B1A47F'></style>
    • <acronym id='C4B7B1A47F'></acronym>
      <center id='C4B7B1A47F'><center id='C4B7B1A47F'><tfoot id='C4B7B1A47F'></tfoot></center><abbr id='C4B7B1A47F'><dir id='C4B7B1A47F'><tfoot id='C4B7B1A47F'></tfoot><noframes id='C4B7B1A47F'>

    • <optgroup id='C4B7B1A47F'><strike id='C4B7B1A47F'><sup id='C4B7B1A47F'></sup></strike><code id='C4B7B1A47F'></code></optgroup>
        1. <b id='C4B7B1A47F'><label id='C4B7B1A47F'><select id='C4B7B1A47F'><dt id='C4B7B1A47F'><span id='C4B7B1A47F'></span></dt></select></label></b><u id='C4B7B1A47F'></u>
          <i id='C4B7B1A47F'><strike id='C4B7B1A47F'><tt id='C4B7B1A47F'><pre id='C4B7B1A47F'></pre></tt></strike></i>

          leisure time

          leisure time

          author:knowledge    Page View:21478
          David Sabatini
          David Sabatini, a biologist who once generated Nobel Prize buzz. Wikimedia Commons

          The 7 a.m. Acela out of South Station in Boston trembled along the rails toward Manhattan. David Sabatini sat alone on the left side of the train. He had brought along a science paper to work on, but had a lot on his mind. He kept his Wordle streak alive on his phone, and stared out at the picturesque Connecticut coastline. His clothing hung loose from recent weight loss, presumably from stress.

          It was Jan. 4, 2022, a brisk sunny day. The tall, gangling scientist with a long mess of black hair had once generated Nobel Prize buzz for his discoveries in biology. But at that moment, he was unemployed in his 50s, his reputation ruined, spending many nights in his brother’s guest room or on his ex-wife’s sofa, so emotionally distraught that his family was afraid to leave him alone.

          advertisement

          Sabatini was journeying to New York in search of a new beginning, an against-all-odds comeback.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          VC firm RA Capital starts a new synthetic biology incubator
          VC firm RA Capital starts a new synthetic biology incubator

          AdobeVenturecapitalfirmRACapitalisstartinganewincubator,settingthestageforthefirmtocreatenewstartups

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          BD to buy Edwards patient monitoring unit for $4.2 billion

          IanWaldie/GettyImagesBectonDickinsonplanstopay$4.2billionforEdwardsLifesciences’criticalcarebusiness